title: [Assessment of the use of various cardiac pacing modes for selection of antiarrhythmic therapy for prevention of recurrent attacks of atrial fibrillation and flutter].
abstract: OBJECTIVE
  To determine optimal mode of transesophageal pacing for selection of appropriate antiarrhythmic therapy for prevention of attacks of atrial fibrillation and flutter in patients with ischemic heart disease.
  
  
  METHODS
  Two hundred eighteen patients with ischemic heart disease and attacks of atrial fibrillation or flutter. Selection of antiarrhythmic drugs was carried out with the use of competitive, rapid, salvos of ultra rapid, and slowly accelerating ultra rapid modes of pacing. Results. Most effective and reproducible method for induction of attacks of atrial flutter and fibrillation was slowly accelerating ultra rapid mode of pacing. Average duration of positive clinical effect of preventive antiarrhythmic therapy selected basing on the results of this mode in patients with ischemic heart disease was 3.1-/+0.3 years. Unfavorable prognostic sign decreasing preventive effect of antiarrhythmic therapy was left atrial dilatation.
  
  
  CONCLUSIONS
  Slowly accelerating mode of transesophageal pacing was most effective tool for selection of antiarrhythmic therapy aimed at prevention of attacks of atrial fibrillation and flutter in patients with ischemic heart disease.
authors.forename: A I
authors.initials: AI
authors.lastname: Olesin
authors.forename: A V
authors.initials: AV
authors.lastname: Shabrov
authors.forename: E A
authors.initials: EA
authors.lastname: Shcheglova
authors.forename: A S
authors.initials: AS
authors.lastname: Anisimova
authors.forename: T V
authors.initials: TV
authors.lastname: Razumova
mesh_terms: D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000145:classification / Q000627:therapeutic use*; D001146:Arrhythmia, Sinus / Q000175:diagnosis* / Q000503:physiopathology / Q000517:prevention & control*; D001281:Atrial Fibrillation / Q000175:diagnosis* / Q000503:physiopathology / Q000517:prevention & control*; D001282:Atrial Flutter / Q000175:diagnosis* / Q000503:physiopathology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence
chemical_list: D000959:Antihypertensive Agents